SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001367644-20-000029
Filing Date
2020-03-06
Accepted
2020-03-06 16:42:18
Documents
1
Period of Report
2020-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 3/A wf-form3a_158353092136096.html 3/A  
1 FORM 3/A wf-form3a_158353092136096.xml 3/A 4328
  Complete submission text file 0001367644-20-000029.txt   5703
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DRIVE SUITE 400 GAITHERSBURG MD 20879
Business Address
Kirk Sean (Reporting) CIK: 0001778426 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-33137 | Film No.: 20695388